Cardiometabolic Outcomes in Transgender Youth

Michele A O'Connell^{1

2

3}, Ken C Pang^{1

2

3}

Affiliations

¹ Department of Adolescent Medicine, The Royal Children's Hospital, Parkville, Victoria, 3052, Australia.
² Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, 3052, Australia.
³ Department of Paediatrics, University of Melbourne, Parkville, Victoria, 3052, Australia.

Editorial

Michele A O'Connell et al. J Clin Endocrinol Metab. 2022.

. 2022 Nov 25;107(12):e4380-e4381.

doi: 10.1210/clinem/dgac592.

Michele A O'Connell^{1

2

3}, Ken C Pang^{1

2

3}

¹ Department of Adolescent Medicine, The Royal Children's Hospital, Parkville, Victoria, 3052, Australia.
² Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, 3052, Australia.
³ Department of Paediatrics, University of Melbourne, Parkville, Victoria, 3052, Australia.

No abstract available

Keywords: adolescents; cardiovascular risk; gender diverse; hormone therapy; transgender.

Comment on

Multicenter Analysis of Cardiometabolic-related Diagnoses in Transgender and Gender-Diverse Youth: A PEDSnet Study.
Valentine A, Davis S, Furniss A, Dowshen N, Kazak AE, Lewis C, Loeb DF, Nahata L, Pyle L, Schilling LM, Sequeira GM, Nokoff N. Valentine A, et al. J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4004-e4014. doi: 10.1210/clinem/dgac469. J Clin Endocrinol Metab. 2022. PMID: 35945152 Free PMC article.